Vaccine adjuvants are substances added to vaccines to enhance the body's immune response to the intended antigen. The primary goal is to improve the vaccine's efficacy by promoting a stronger, longer-lasting, and more robust immune reaction. Common adjuvants include aluminum salts (alum), which have been used for decades and are found in various vaccines. Other adjuvants include oil-in-water emulsions, liposomes, and virosomes. These adjuvants often stimulate a more significant production of antibodies and activate immune cells, contributing to a heightened defense against pathogens. Adjuvants play a crucial role in enhancing vaccine effectiveness, especially in situations where a strong immune response is needed, such as in certain populations or against rapidly evolving pathogens. They enable the use of lower vaccine doses while still achieving optimal protection. Research in vaccine adjuvants focuses on understanding their mechanisms of action, optimizing formulations, and ensuring safety. Balancing enhanced immunogenicity with minimal side effects is crucial in developing effective and well-tolerated vaccines for a variety of infectious diseases.
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Home-based HPV self-sampling assisted by a cloud-based electronic data system: Lessons learnt from a pilot community cervical cancer screening campaign in rural Ethiopia, May 2020
Temesgen Azemeraw Yitayew, Addis Ababa University, Ethiopia